Good points ,, the offer was for Non Neural that LCT received an offer in 2017 to support the company to complete a clinical trial of transplantation of NTCELL to validate it as a treatment for a non-neurology related application that has a current overall treatment market of USD4.9b per annum.We understand that MedSafe would allow a PhaseII study and that there is a large global unmet need for such a potential treatment for the targeted application.....
I would have thought the company would have announced such a commercial offer? especially for application outside Neural...
That was news to me ,,did anyone else know of this offer??
- Forums
- ASX - By Stock
- Pacific Channel releases its internal analysis of LCT 13/05/2019
Good points ,, the offer was for Non Neural that LCT received an...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add 1AI (ASX) to my watchlist
|
|||||
Last
0.7¢ |
Change
-0.001(12.5%) |
Mkt cap ! $11.81M |
Open | High | Low | Value | Volume |
0.7¢ | 0.8¢ | 0.7¢ | $21.26K | 3.022M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 8514049 | 0.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.8¢ | 1168300 | 11 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 8514049 | 0.007 |
11 | 5986749 | 0.006 |
8 | 6110009 | 0.005 |
4 | 4065000 | 0.004 |
2 | 4590000 | 0.003 |
Price($) | Vol. | No. |
---|---|---|
0.008 | 1168300 | 11 |
0.009 | 1871161 | 10 |
0.010 | 1027472 | 3 |
0.011 | 1490400 | 3 |
0.012 | 363666 | 3 |
Last trade - 16.10pm 11/09/2024 (20 minute delay) ? |
Featured News
1AI (ASX) Chart |